1. Adams, I. B., Compton, D. R. and Martin, B. R. (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther.
284, 1209–1217.
2. Adams, I. B., Ryan, W., Singer, M., Thomas, B. F., Compton, D. R., Razdan, R. K. and Martin, B. R. (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273, 1172–1181.
3. Barg, J., Fride, E., Hanus, L., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M., Mechoulam, R. and Vogel, Z. (1995) Cannabimimetic behavioral effects and adenylate cyclase inhibition by two new endogenous anandamides. Eur. J. Pharmacol.
287, 145–152.
4. Basbaum, A. I. and Fields, H. L. (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7, 309–338.
5. Bell, M. R., D’Ambra, T. E., Kumar, V., Eissenstat, M. A., Herrmann, J. L., Wetzel, J. R., Rosi, D., Philion, R. E., Daum, S. J., Hlasta, D. J., Kullnig, R. K., Ackerman, J. H., Haubrich, D. R., Luttinger, D. A., Baizman, E. R., Miller, M. S. and Ward, S. J. (1991) Antinociceptive (aminoalkyl)indoles. J. Med. Chem.
34, 1099–1110.